ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 47 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $690,616 | -18.9% | 116,658 | +1.6% | 0.00% | – |
| Q2 2023 | $851,883 | +68.1% | 114,809 | +114.0% | 0.00% | – |
| Q1 2023 | $506,917 | -19.3% | 53,642 | -9.1% | 0.00% | – |
| Q4 2022 | $628,468 | +44.5% | 59,011 | 0.0% | 0.00% | – |
| Q3 2022 | $435,000 | +77.6% | 59,011 | +16.2% | 0.00% | – |
| Q2 2022 | $245,000 | -5.4% | 50,793 | 0.0% | 0.00% | – |
| Q1 2022 | $259,000 | -15.1% | 50,793 | 0.0% | 0.00% | – |
| Q4 2021 | $305,000 | -32.2% | 50,793 | 0.0% | 0.00% | – |
| Q3 2021 | $450,000 | +11.9% | 50,793 | 0.0% | 0.00% | – |
| Q2 2021 | $402,000 | +3.9% | 50,793 | 0.0% | 0.00% | – |
| Q1 2021 | $387,000 | -10.8% | 50,793 | -8.8% | 0.00% | – |
| Q4 2020 | $434,000 | +5.3% | 55,665 | +30.9% | 0.00% | – |
| Q3 2020 | $412,000 | – | 42,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |